Key result
Low-dose droxidopa linked to severe hypertensive emergency and reversible cerebral edema in pure autonomic failure.
Case Report (n=1)
No
Severe hypertensive complications with reversible cerebral edema may occur during low-dose droxidopa initiation in vulnerable patients with advanced autonomic dysfunction.
Answers are grounded in this paper and cite their sources.
Severe hypertensive emergency with cerebral edema may occur even at low-dose droxidopa in PAF; single case leaves open true incidence and risk stratification.
Pure autonomic failure (PAF) is characterized by neurogenic orthostatic hypotension and marked blood pressure (BP) lability. Droxidopa is widely used for symptomatic management and is generally well tolerated. We report a 60-year-old woman with advanced PAF who developed a hypertensive emergency with vasogenic cerebral edema shortly after initiation of low-dose droxidopa. This case highlights that severe hypertensive complications with reversible cerebral edema may occur even during low-dose droxidopa initiation in vulnerable patients with advanced autonomic dysfunction, underscoring the need for cautious dose titration and close BP monitoring.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) conducted a case report in Pure autonomic failure (n=1). Droxidopa was evaluated on Hypertensive emergency with vasogenic cerebral edema. Initiation of low-dose droxidopa in a patient with advanced pure autonomic failure led to a severe hypertensive emergency with reversible vasogenic cerebral edema.
Synapse has enriched 10 related papers. Consider them for comparative context: